Auteurs
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Auteurs » - entrée « Mari Miyoshi »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Mari Lynne Silverberg < Mari Miyoshi < Mari S. Oba  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 5.
Ident.Authors (with country if any)Title
001328 (2014) Shumpei Yokota [Japon] ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu KishimotoLongterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan.
001559 (2013) Shumpei Yokota ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu KishimotoLong-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan.
001667 (2012) Masaki Shimizu [Japon] ; Yasuo Nakagishi ; Kazuko Kasai ; Yuichi Yamasaki ; Mari Miyoshi ; Syuji Takei ; Akihiro YachieTocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6.
001713 (2012) Tomoyuki Imagawa [Japon] ; Shumpei Yokota ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Hiroyuki Imanaka ; Yasuhito Nerome ; Naomi Iwata ; Takuji Murata ; Mari Miyoshi ; Norihiro Nishimoto ; Tadamitsu KishimotoSafety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis.
001B61 (2008) Shumpei Yokota [Japon] ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Yukoh Aihara ; Shuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu KishimotoEfficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "Mari Miyoshi" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i  \
                -Sk "Mari Miyoshi" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Mari Miyoshi
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021